Joël Uzzan

794 total citations · 1 hit paper
17 papers, 416 citations indexed

About

Joël Uzzan is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Joël Uzzan has authored 17 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Ophthalmology, 12 papers in Radiology, Nuclear Medicine and Imaging and 1 paper in Molecular Biology. Recurrent topics in Joël Uzzan's work include Retinal Diseases and Treatments (16 papers), Retinal and Optic Conditions (7 papers) and Retinal Imaging and Analysis (7 papers). Joël Uzzan is often cited by papers focused on Retinal Diseases and Treatments (16 papers), Retinal and Optic Conditions (7 papers) and Retinal Imaging and Analysis (7 papers). Joël Uzzan collaborates with scholars based in France, Italy and Switzerland. Joël Uzzan's co-authors include Florence Coscas, G. Coscas, A. Glacet–Bernard, Eric H. Souied, Alexandra Mière, Violaine Caillaux, Marco Lupidi, Salomon Y. Cohen, Ramin Tadayoni and Hassiba Oubraham and has published in prestigious journals such as Ophthalmology, American Journal of Ophthalmology and Retina.

In The Last Decade

Joël Uzzan

16 papers receiving 400 citations

Hit Papers

Optical Coherence Tomography Angiography in Retinal Vein ... 2015 2026 2018 2022 2015 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joël Uzzan France 8 393 288 43 34 24 17 416
Magdalena A. Wirth Switzerland 10 357 0.9× 297 1.0× 36 0.8× 35 1.0× 28 1.2× 27 428
Alessandro Papayannis Italy 11 431 1.1× 321 1.1× 42 1.0× 30 0.9× 38 1.6× 26 463
Gerardo Ledesma‐Gil United States 12 326 0.8× 231 0.8× 23 0.5× 22 0.6× 33 1.4× 40 363
Paulo Stanga United Kingdom 12 415 1.1× 334 1.2× 70 1.6× 42 1.2× 51 2.1× 33 467
Hideki Shiihara Japan 11 336 0.9× 304 1.1× 43 1.0× 23 0.7× 24 1.0× 40 367
Jonathan Naysan United States 9 470 1.2× 343 1.2× 23 0.5× 23 0.7× 49 2.0× 15 493
Francesco Gelormini Italy 12 478 1.2× 418 1.5× 55 1.3× 20 0.6× 42 1.8× 34 511
James M. Heltzer United States 5 296 0.8× 203 0.7× 32 0.7× 33 1.0× 12 0.5× 5 341
Tarek Alasil United States 11 625 1.6× 488 1.7× 80 1.9× 32 0.9× 57 2.4× 24 681
Baldo Scassellati-Sforzolini Italy 10 479 1.2× 271 0.9× 27 0.6× 18 0.5× 34 1.4× 20 523

Countries citing papers authored by Joël Uzzan

Since Specialization
Citations

This map shows the geographic impact of Joël Uzzan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joël Uzzan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joël Uzzan more than expected).

Fields of papers citing papers by Joël Uzzan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joël Uzzan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joël Uzzan. The network helps show where Joël Uzzan may publish in the future.

Co-authorship network of co-authors of Joël Uzzan

This figure shows the co-authorship network connecting the top 25 collaborators of Joël Uzzan. A scholar is included among the top collaborators of Joël Uzzan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joël Uzzan. Joël Uzzan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Uzzan, Joël, et al.. (2024). Clinical Outcomes and Experiences with Prefilled Syringes Versus Vials for Intravitreal Administration of Anti-VEGF Treatments: A Systematic Review. Ophthalmology and Therapy. 13(9). 2445–2465. 3 indexed citations
3.
Serra, Rita, Florence Coscas, Diogo Cabral, et al.. (2024). Optical coherence tomography angiography macular biomarkers of peripheral retinal ischemia in diabetic macular edema: secondary endpoints from the clinical study “FOVEA”. Graefe s Archive for Clinical and Experimental Ophthalmology. 262(6). 1777–1783. 1 indexed citations
4.
Gabrielle, Pierre‐Henry, Marie‐Noëlle Delyfer, A. Glacet–Bernard, et al.. (2023). Surgery, Tissue Plasminogen Activator, Antiangiogenic Agents, and Age-Related Macular Degeneration Study. Ophthalmology. 130(9). 947–957. 15 indexed citations
5.
Crincoli, Emanuele, Oudy Semoun, Joël Uzzan, et al.. (2022). Undetectable Macular Neovascularization on OCT Angiography in Age Related Macular Degeneration: Comparison between Different Devices. Medicina. 58(9). 1246–1246. 3 indexed citations
6.
Couturier, Aude, Laurent Kodjikian, Stéphanie Baillif, et al.. (2021). Consensus d’experts français sur les critères de choix d’un traitement de 1re intention dans la DMLA néovasculaire et importance du ratio bénéfice/risque à long terme. Journal Français d Ophtalmologie. 44(7). 937–946. 1 indexed citations
7.
Tran, Thi Hà Châu, Ali Erginay, Stéphane Verdun, et al.. (2021). One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema. Clinical ophthalmology. Volume 15. 1971–1978. 4 indexed citations
8.
Devin, François, et al.. (2017). Evaluation of time-to-recurrence of disease activity in treatment-naïve patients with neovascular age-related macular degeneration after ranibizumab treatment: 12-month analysis from the ORACLE study. 58(8). 900–900. 1 indexed citations
9.
Blanco-Garavito, Rocío, Camille Jung, Joël Uzzan, et al.. (2017). AFLIBERCEPT AFTER RANIBIZUMAB INTRAVITREAL INJECTIONS IN EXUDATIVE AGE–RELATED MACULAR DEGENERATION. Retina. 38(12). 2285–2292. 7 indexed citations
10.
Jung, Camille, Rocío Blanco-Garavito, Oudy Semoun, et al.. (2016). Change in Pigment Epithelial Detachment Volume and its Relationship with Subretinal Fluid and Visual Acuity in Patients with Exudative AMD after Aflibercept Switch Therapy. Post hoc analysis from the ARI2 Study.. 57(12). 519–519. 18 indexed citations
11.
Coscas, Florence, A. Glacet–Bernard, Alexandra Mière, et al.. (2015). Optical Coherence Tomography Angiography in Retinal Vein Occlusion: Evaluation of Superficial and Deep Capillary Plexa. American Journal of Ophthalmology. 161. 160–171.e2. 259 indexed citations breakdown →
12.
Bats, F. De, et al.. (2015). Fundus autofluorescence imaging in White Dot Syndromes. Acta Ophthalmologica. 93(S255). 2 indexed citations
13.
Cohen, Salomon Y., Hassiba Oubraham, Joël Uzzan, Lise Dubois, & Ramin Tadayoni. (2012). CAUSES OF UNSUCCESSFUL RANIBIZUMAB TREATMENT IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION IN CLINICAL SETTINGS. Retina. 32(8). 1480–1485. 46 indexed citations
14.
Coscas, G., Qienyuan Zhou, Florence Coscas, et al.. (2012). Choroid Thickness Measurement with RTVue Optical Coherence Tomography in Emmetropic Eyes, Mildly Myopic Eyes, and Highly Myopic Eyes. European Journal of Ophthalmology. 22(6). 992–1000. 36 indexed citations
15.
Oubraham, Hassiba & Joël Uzzan. (2009). 189 Néovaisseaux choroïdiens rétro-fovéolaires du myope fort : analyse au long cours de l’acuité visuelle après traitement par Ranibizumab. Journal Français d Ophtalmologie. 32. 1S69–1S69. 2 indexed citations
16.
Benhamou, Nathanaël, Salomon Y. Cohen, Ali Erginay, et al.. (2004). Macular burn after transpupillary thermotherapy for occult choroidal neovascularization. American Journal of Ophthalmology. 137(6). 1132–1135. 11 indexed citations
17.
Brasseur, Gérard, et al.. (1993). [Ultrasonographic study of posterior vitreous detachment in emmetropic eyes].. PubMed. 16(10). 538–44. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026